Literature DB >> 28747504

Targeted Genome Sequencing Reveals Varicella-Zoster Virus Open Reading Frame 12 Deletion.

Randall J Cohrs1,2, Katherine S Lee3, Addilynn Beach4, Bridget Sanford5, Nicholas L Baird4, Christina Como4, Chiharu Graybill3, Dallas Jones4, Eden Tekeste6, Mitchell Ballard6, Xiaomi Chen4, David Yalacki7, Seth Frietze8, Kenneth Jones9, Tihana Lenac Rovis10, Stipan Jonjić10, Jürgen Haas11,12, Don Gilden4,2.   

Abstract

The neurotropic herpesvirus varicella-zoster virus (VZV) establishes a lifelong latent infection in humans following primary infection. The low abundance of VZV nucleic acids in human neurons has hindered an understanding of the mechanisms that regulate viral gene transcription during latency. To overcome this critical barrier, we optimized a targeted capture protocol to enrich VZV DNA and cDNA prior to whole-genome/transcriptome sequence analysis. Since the VZV genome is remarkably stable, it was surprising to detect that VZV32, a VZV laboratory strain with no discernible growth defect in tissue culture, contained a 2,158-bp deletion in open reading frame (ORF) 12. Consequently, ORF 12 and 13 protein expression was abolished and Akt phosphorylation was inhibited. The discovery of the ORF 12 deletion, revealed through targeted genome sequencing analysis, points to the need to authenticate the VZV genome when the virus is propagated in tissue culture.IMPORTANCE Viruses isolated from clinical samples often undergo genetic modifications when cultured in the laboratory. Historically, VZV is among the most genetically stable herpesviruses, a notion supported by more than 60 complete genome sequences from multiple isolates and following multiple in vitro passages. However, application of enrichment protocols to targeted genome sequencing revealed the unexpected deletion of a significant portion of VZV ORF 12 following propagation in cultured human fibroblast cells. While the enrichment protocol did not introduce bias in either the virus genome or transcriptome, the findings indicate the need for authentication of VZV by sequencing when the virus is propagated in tissue culture.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  ORF 12; VZV; deletion; genome; transcriptome

Mesh:

Substances:

Year:  2017        PMID: 28747504      PMCID: PMC5625521          DOI: 10.1128/JVI.01141-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  66 in total

1.  BIOLOGIC CHARACTERISTICS OF A CONTINUOUS KIDNEY CELL LINE DERIVED FROM THE AFRICAN GREEN MONKEY.

Authors:  H E HOPPS; B C BERNHEIM; A NISALAK; J H TJIO; J E SMADEL
Journal:  J Immunol       Date:  1963-09       Impact factor: 5.422

Review 2.  VZV T cell-mediated immunity.

Authors:  Adriana Weinberg; Myron J Levin
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

3.  Restricted varicella-zoster virus transcription in human trigeminal ganglia obtained soon after death.

Authors:  Werner J D Ouwendijk; Alexander Choe; Maria A Nagel; Don Gilden; Albert D M E Osterhaus; Randall J Cohrs; Georges M G M Verjans
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

4.  Successful antiviral treatment after 6years of chronic progressive neurological disease attributed to VZV brain infection.

Authors:  Don Gilden; Charles Grose; Teresa White; Lidia Nagae; Robert L Hendricks; Randall J Cohrs; Maria A Nagel
Journal:  J Neurol Sci       Date:  2016-07-15       Impact factor: 3.181

5.  Varicella-Zoster virus ORF12 protein triggers phosphorylation of ERK1/2 and inhibits apoptosis.

Authors:  Xueqiao Liu; Qingxue Li; Kennichi Dowdell; Elizabeth R Fischer; Jeffrey I Cohen
Journal:  J Virol       Date:  2012-01-11       Impact factor: 5.103

6.  Varicella-zoster virus infects human embryonic stem cell-derived neurons and neurospheres but not pluripotent embryonic stem cells or early progenitors.

Authors:  Anna Dukhovny; Anna Sloutskin; Amos Markus; Michael B Yee; Paul R Kinchington; Ronald S Goldstein
Journal:  J Virol       Date:  2012-01-11       Impact factor: 5.103

7.  Genotype analysis of varicella-zoster virus isolates from suburban Shanghai Municipal Province, China.

Authors:  Z Sun; Y Guo; M Li; Z Yao
Journal:  J Med Microbiol       Date:  2015-12-09       Impact factor: 2.472

8.  An in vitro model of latency and reactivation of varicella zoster virus in human stem cell-derived neurons.

Authors:  Amos Markus; Ilana Lebenthal-Loinger; In Hong Yang; Paul R Kinchington; Ronald S Goldstein
Journal:  PLoS Pathog       Date:  2015-06-04       Impact factor: 6.823

9.  Evolution of cocirculating varicella-zoster virus genotypes during a chickenpox outbreak in Guinea-Bissau.

Authors:  Daniel P Depledge; Eleanor R Gray; Samit Kundu; Samantha Cooray; Anja Poulsen; Peter Aaby; Judith Breuer
Journal:  J Virol       Date:  2014-10-01       Impact factor: 5.103

10.  Viral Genome Sequencing Proves Nosocomial Transmission of Fatal Varicella.

Authors:  Daniel P Depledge; Julianne Brown; Jasna Macanovic; Gill Underhill; Judith Breuer
Journal:  J Infect Dis       Date:  2016-08-28       Impact factor: 7.759

View more
  3 in total

1.  Long-read sequencing uncovers a complex transcriptome topology in varicella zoster virus.

Authors:  István Prazsák; Norbert Moldován; Zsolt Balázs; Dóra Tombácz; Klára Megyeri; Attila Szűcs; Zsolt Csabai; Zsolt Boldogkői
Journal:  BMC Genomics       Date:  2018-12-04       Impact factor: 3.969

2.  Uncovering Bifidobacteria via Targeted Sequencing of the Mammalian Gut Microbiota.

Authors:  Gabriele Andrea Lugli; Sabrina Duranti; Christian Milani; Leonardo Mancabelli; Francesca Turroni; Douwe van Sinderen; Marco Ventura
Journal:  Microorganisms       Date:  2019-11-06

3.  Ultrasensitive Capture of Human Herpes Simplex Virus Genomes Directly from Clinical Samples Reveals Extraordinarily Limited Evolution in Cell Culture.

Authors:  Alexander L Greninger; Pavitra Roychoudhury; Hong Xie; Amanda Casto; Anne Cent; Gregory Pepper; David M Koelle; Meei-Li Huang; Anna Wald; Christine Johnston; Keith R Jerome
Journal:  mSphere       Date:  2018-06-13       Impact factor: 4.389

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.